Likewise, 60% of patients with anti-Contactin-associated Protein-Like 2 (CASPR2) encephalitis were found to have persistent fatigue and neuropathic pain at 6 months and 48 months post-treatment [13]. This evidence concerns the gene CNTNAP2 and viral encephalitis.